Tag Archives: mRNA

EQT Private Equity gab die Übernahme von SPT Labtech von Battery Ventures für 650 Millionen GBP bekannt

(PRESSEMITTEILUNG) STOCKHOLM, 22-Jun-2022 — /EuropaWire/ — EQT AB, eine zweckorientierte globale Investmentgesellschaft, hat die Übernahme von SPT Labtech bekannt gegeben von Battery Ventures, einer globalen, technologieorientierten Investmentgesellschaft, für 650 Mio. GBP (~ 756 Mio. EUR). SPT Labtech ist ein britisches … Read the full press release

EQT Private Equity announced the acquisition of SPT Labtech from Battery Ventures for GBP 650 million

(PRESS RELEASE) STOCKHOLM, 22-Jun-2022 — /EuropaWire/ — EQT AB, a purpose-driven global investment organization, has announced the acquisition of SPT Labtech from Battery Ventures, a global, technology-focused investment firm, for GBP 650 million (~ EUR 756 million). SPT Labtech is … Read the full press release

WACKER and CordenPharma joint bid to become part of Germany’s Pandemic Preparedness Plan has been accepted

(PRESS RELEASE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR: WCH), a German multinational chemical company, and CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), have announced that their joint bid to … Read the full press release

Sanofi adds first vaccine candidate against acne to its R&D pipeline with the take over of an Austrian privately held biotechnology firm

Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide Sanofi to leverage its next-generation mRNA platform to unlock … Read the full press release

Kuehne+Nagel takes responsibility of global distribution of Covid-19 Vaccine Moderna

New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 — /EuropaWire/ — Global transport and logistics company Kuehne+Nagel announces international supply chain arrangement with Moderna, Inc. (NASDAQ:MRNA), a biotechnology company … Read the full press release

Sanofi announces second collaboration as it strives to develop a novel COVID-19 vaccine candidate

(PRESS RELEASE) PARIS and LEXINGTON, MA, U.S.A, 27-Mar-2020 — /EuropaWire/ — Sanofi Pasteur collaborates with Translate Bio (NASDAQ: TBIO) to develop a novel mRNA vaccine for COVID-19. Both companies will jointly investigate multiple candidates with the goal of advancing an … Read the full press release